Press releases
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
28 Mar 24
Press Releases
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
12 Feb 24
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
6 Feb 24
Health Care, Press Releases, General
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA
8 Jan 24
Press Releases